Top Markets
#1 Orochi Network Orochi Network +71.79%
#2 Bitway Bitway +26.52%
#3 Audiera Audiera +23.90%
#4 RSK Infrastructure Framework RSK Infrastructure Framework +17.56%
#5 Pharos Pharos +16.09%
#6 SOON SOON +14.94%
#7 Taiko Taiko +14.59%
#8 Cheems Token Cheems Token +14.34%
#9 Manadia Manadia +14.25%
#10 Zilliqa Zilliqa +12.53%
Coin of the day
Orochi Network Orochi Network
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
Clasificación en acciones #72
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Precio por acción
$50.93
Capitalización bursátil
$226.32B
Cambio (1 día)
2.54%
Cambio (1 año)
-26.19%
País
DK
Comercio Novo Nordisk A/S (NVO)

Categoría

Healthcare
Ratio P/B de Novo Nordisk A/S (NVO)
Ratio P/B al July 2026 TTM: 6.99
Según los informes financieros más recientes y el precio de las acciones de Novo Nordisk A/S, el ratio P/B actual (TTM) es 6.99. Al final de 2024, el ratio P/B era 19.38.
Historial del ratio P/B de Novo Nordisk A/S desde 2000 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
2026 (TTM) 6.99 -6.12%
2025 7.45 -61.56%
2024 19.38 -34.02%
2023 29.37 15.39%
2022 25.45 6.65%
2021 23.87 51.77%
2020 15.72 -1.35%
2019 15.94 12.22%
2018 14.20 -14.34%
2017 16.58 16.48%
2016 14.23 -34.97%
2015 21.89 29.23%
2014 16.94 35.36%
2013 12.51 -0.67%
2012 12.60 26.42%
2011 9.97 0.88%
2010 9.88 77.44%
2009 5.57 9.91%
2008 5.07 -20.41%
2007 6.36 25.26%
2006 5.08 20.40%
2005 4.22 11.39%
2004 3.79 16.59%
2003 3.25 4.96%
2002 3.10 -47.14%
2001 5.86 -4.54%
2000 6.14 0.00%
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.251 -10.63%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 2.1715 -68.95%
US
UCB SA UCB SA
UCB SA
UCB.BR
 4.065 -41.88%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 7.3009 4.39%
NL
Alnylam Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
ALNY.US
 34.7575 396.95%
US